Bloomberg Businessweek
US Core CPI Remains Firm for Third Straight Month With 0.3% Gain
Nov 13, 2024
Andy Marsh, CEO of Plug Power, discusses the future of green hydrogen and its pivotal role in the energy sector, especially amidst potential political shifts. Tyler Kendall, a Bloomberg News political reporter, shares insights from President Biden's recent meeting with President-elect Trump and the implications for federal policies. The conversation dives into inflation trends and how they interact with upcoming political dynamics, touching on the challenges and opportunities in navigating energy markets.
42:17
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Vertex Pharmaceuticals is leveraging advanced genetic technologies like CRISPR to create targeted therapies for complex diseases, revolutionizing treatment approaches.
- The potential implications of a Trump administration on tariffs and trade policies indicate a need for careful balance between regulation and free trade in shaping economic strategies.
Deep dives
Vertex Pharmaceuticals' Innovative Approach
Vertex Pharmaceuticals employs a unique philosophy and innovative tools to tackle some of humanity's toughest diseases, including cystic fibrosis and sickle cell disease. The company's commitment to research and development is grounded in understanding the specific genetic causes of these disorders, enabling them to create targeted therapies. By utilizing advanced genetic editing techniques like CRISPR and other cutting-edge technologies, Vertex aims to unlock new possibilities in treatment. Their success in bringing novel therapies to market reflects their dedication to challenging the conventional approaches in the pharmaceutical industry.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
